WCN24-733 Treatment decision-making modle for IgA nephropathy: a real-world study

WCN24-733 Treatment decision-making modle for IgA nephropathy: a real-world study

Saved in:

Bibliographic Details
Main Authors:	Ying Zheng, Delong Zhao, Yan Mei, Shan Qiao, Shuwei Duan, Guangyan Cai, Xiangmei Chen
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924003784
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-1863 Towards an IgA Nephropathy Atlas
by: Julio Saez-Rodriguez, et al.
Published: (2024-04-01)

IKZF1 as a potential therapeutic target for dendritic cell-mediated immunotherapy in IgA nephropathy
by: Fei Peng, et al.
Published: (2025-05-01)

WCN24-1121 Novel IgA type autoantibodies against mesangial autoantigen, βIIspectrin, are specifically detected in patients with IgA nephropathy
by: Kazuaki Mori, et al.
Published: (2024-04-01)

WCN24-2062 CLINICOPATHOLOGICAL CHARACTERISTICS AND LONG-TERM PROGNOSIS OF IgA NEPHROPATHY PATIENTS WITH NEPHROTIC SYNDROME
by: xiaoling zhou, et al.
Published: (2024-04-01)

IgA Nephropathy in the Elderly
by: Dana V. Rizk, et al.
Published: (2025-08-01)

WCN25-4505 A DESCRIPTIVE STUDY ON THE CLINICOPATHOLOGICAL PROFILE AND TREATMENT OUTCOME OF IgA NEPHROPATHY USING THE INTERNATIONAL IgA NEPHROPATHY PREDICTION TOOL
by: Arghya Chakraborty, et al.
Published: (2025-02-01)

WCN24-1197 EFFICACY AND SAFETY OF RAVULIZUMAB IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL IN IgA NEPHROPATHY
by: Jonathan Barratt, et al.
Published: (2024-04-01)

WCN24-1506 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY
by: Vlado Perkovic, et al.
Published: (2024-04-01)

Is Childhood IgA Nephropathy Different From Adult IgA Nephropathy? A Narrative Review
by: Areefa Alladin-Karan, et al.
Published: (2025-03-01)

WCN24-186 JAK/STAT EXPRESSION IN PATIENTS WITH IGA NEPHROPATHY
by: Mateus Luvizotto, et al.
Published: (2024-04-01)

WCN24-2606 KIDNEY RE-BIOPSY IN ADULTS WITH IGA NEPHROPATHY
by: Leonel Langellotti, et al.
Published: (2024-04-01)

WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
by: Jonathan Barratt, et al.
Published: (2025-02-01)

WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN)
by: Jonathan Barratt, et al.
Published: (2025-02-01)

Application of hydroxychloroquine for IgA nephropathy
by: Xiao Yong-zhen, et al.
Published: (2021-01-01)

Unconventional T Cells in IgA Nephropathy
by: Zizhang Sheng, et al.
Published: (2025-02-01)

Effect of Telitacicept on Circulating Gd-IgA1 and IgA-Containing Immune Complexes in IgA Nephropathy
by: Jincan Zan, et al.
Published: (2024-04-01)

Corrigendum to “Is childhood IgA nephropathy different from adult IgA nephropathy? A narrative review”
Published: (2025-07-01)

WCN25-1709 Salivary and Urinary Metabolomics Study in IgA Nephropathy Patients
by: Rümeyza Kazancıoğlu, et al.
Published: (2025-02-01)

WCN25-844 FELZARTAMAB FOR IgA NEPHROPATHY: FINAL RESULTS OF THE IGNAZ STUDY
by: Uptal Patel, et al.
Published: (2025-02-01)

Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.
by: Qiang Sun, et al.
Published: (2016-01-01)

Carboxymethyl-lysine is a Prominent Target of Circulating IgA in IgA Nephropathy
by: Sara Alibrandi, et al.
Published: (2025-07-01)

Aberrantly Glycosylated IgA1 as a Factor in the Pathogenesis of IgA Nephropathy
by: Mototsugu Tanaka, et al.
Published: (2011-01-01)

WCN24-1104 Finding of CD4+ T cells infiltrating the kidney of gddY mouse, IgA nephropathy animal model
by: Hiroyuki Iwasaki, et al.
Published: (2024-04-01)

WCN24-1565 EFFECT OF PHOSPHODIESTERASE V INHIBITOR ON FIBROBLAST DERIVED FROM BIOPSY SPECIMEN OF IgA NEPHROPATHY: AN IN-VITRO STUDY
by: Manas Ranjan Behera, et al.
Published: (2024-04-01)

WCN24-773 SPARSENTAN AS FIRST-LINE TREATMENT OF INCIDENT PATIENTS WITH IgA NEPHROPATHY: PRELIMINARY FINDINGS FROM THE SPARTAN TRIAL
by: Chee Kay Cheung, et al.
Published: (2024-04-01)

Iron metabolism and chronic inflammation in IgA nephropathy
by: Zhang-yu Tian, et al.
Published: (2023-12-01)

Significance of serum IgA/C3 ratio in the diagnosis and prognosis of IgA nephropathy
by: XIE Wei-ji, et al.
Published: (2019-01-01)

Opportunities and challenges in the treatment of IgA nephropathy
by: Yang Yang, et al.
Published: (2025-07-01)

Characterisation of IgA Nephropathy in an Australian Cohort
by: Shriram Swaminathan, et al.
Published: (2025-01-01)

Serum Cytokine Profile in IgA Nephropathy
by: Friederike Selbach, MD, et al.
Published: (2025-02-01)

Research advances on the pathogenesis of IgA nephropathy
by: Lu Fang-cao, et al.
Published: (2022-02-01)

Influencing factors of IgA nephropathy combined with hyperuricemia and a nomogram to predict the risk of hyperuricemia in IgA nephropathy patients
by: Zhou Jie, et al.
Published: (2025-01-01)

Influencing factors of IgA nephropathy combined with hyperuricemia and a nomogram to predict the risk of hyperuricemia in IgA nephropathy patients
by: Zhou Jie, et al.
Published: (2025-01-01)

Relationship between Gd-IgA1 and TNFR1 in IgA nephropathy and IgA vasculitis nephritis in children – multicenter study
by: Małgorzata Mizerska-Wasiak, et al.
Published: (2021-08-01)

WCN24-2410 “ASSOCIATION OF GLOMERULAR SYNDROMES WITH HISTOLOGICAL FINDINGS ACCORDING TO THE MEST-C SCORE OF THE OXFORD CLASSIFICATION IN PATIENTS WITH IgA NEPHROPATHY”
by: NIDIAANAHIMOLINA GONZÁLEZ, et al.
Published: (2024-04-01)

WCN24-2478 PODOCYTOPATHY ASSOCIATED WITH IGA NEPHROPATHY: IS IT REALLY A PROGNOSTIC FACTOR?
by: BELENGALLEGOS VAZQUEZ, et al.
Published: (2024-04-01)

Serum IgA/C3 ratio as a diagnostic and prognostic biomarker for IgA nephropathy
by: Anitha Swamy, et al.
Published: (2025-08-01)

Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
by: Colin Reily, et al.
Published: (2014-01-01)

Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy
by: Hitoshi Irabu, et al.
Published: (2020-01-01)

Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
by: M. Colleen Hastings, et al.
Published: (2012-01-01)